Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-07
2007-08-07
Stockton, Laura L. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S404000, C514S339000, C514S341000, C548S364100, C546S276100
Reexamination Certificate
active
10525111
ABSTRACT:
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I):wherein: R1, R2, R5, R6, R6a, R7, R8, A, B and M are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
REFERENCES:
patent: WO 97/21435 (1997-06-01), None
patent: WO 97/21703 (1997-06-01), None
patent: WO 97/21704 (1997-06-01), None
patent: WO 97/21707 (1997-06-01), None
patent: 97/44339 (1997-11-01), None
patent: WO 97/44339 (1997-11-01), None
patent: WO 98/55116 (1998-12-01), None
patent: WO 98/55119 (1998-12-01), None
patent: WO 98/55123 (1998-12-01), None
patent: WO 98/55470 (1998-12-01), None
patent: WO 98/55479 (1998-12-01), None
patent: WO 99/21553 (1999-05-01), None
patent: WO 99/21557 (1999-05-01), None
patent: WO 99/41251 (1999-08-01), None
patent: WO 99/41252 (1999-08-01), None
patent: WO 99/51231 (1999-10-01), None
patent: WO 99/51232 (1999-10-01), None
patent: WO 99/51233 (1999-10-01), None
patent: WO 99/51234 (1999-10-01), None
patent: WO 99/51595 (1999-10-01), None
patent: WO 99/51596 (1999-10-01), None
patent: 00/04013 (2000-01-01), None
patent: WO 00/04013 (2000-01-01), None
patent: WO 00/53178 (2000-08-01), None
patent: WO 00/53179 (2000-08-01), None
patent: WO 00/53180 (2000-08-01), None
patent: WO 00/53181 (2000-08-01), None
patent: WO 00/53185 (2000-08-01), None
patent: WO 00/53602 (2000-08-01), None
patent: WO 00/69433 (2000-11-01), None
patent: WO 02/66459 (2002-08-01), None
patent: WO 02/92565 (2002-11-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Ashton et al ‘Substituted Indole-5-carboxamides and -acetamides as Potent Nonpeptide GnRH Receptor Antagonist.’ Bioorganic & Medicinal Chemistry Letters, 2001, vol. 11, pp. 1723-1726.
Ashton et al ‘Potent Nonpeptide GnHR Receptor Antagonists Derived from Substituted Indole-5-carboxamides and -acetamides Bearing a Pyridine Side-Chain Terminus.’ Bioorganic & Medicinal Chemistry Letters, 2001, vol. 11, pp. 1727-1731.
Ashton et al ‘Orally Bioavailable, Indole-Based Nonpeptide GnHR Receptor Antagonists with High Potancy and Functional Activity.’ Bioorganic and medicinal Chemistry Letters, 2001, vol. 11, pp. 2597-2602.
Chu et al ‘Initial Structure-Activity Relationship of a Novel Class of Nonpeptidyl GnHR Receptor Antagonists: 2-Arylindoles.’ Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, pp. 509-513.
Chu et al ‘SAR Studies of novel 5-Substituted 2-Arylindoles as Nonpeptidyl GnHR Receptor Antagonists.’ Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, pp. 515-517.
Freidinger, R, M. ‘Nonpeptide ligands for peptide and protein receptors.’ Current Opinion in Chemical Biology, 1999, vol. 3, pp. 395-406.
Goulet, M, T. ‘Gonadotropin Releasing Hormone Antagonists.’ Annual Reports in Medicinal Chemistry, 1995, vol. 30, pp. 169-178.
Lin, et al ‘2-(3,5-Dimethylphenyl)tryptamine Derivatives That Bind to the GnHR Receptor.’ Bioorganic & Medicinal Chemistry Letters, 2001, vol. 11, pp. 1073-1076.
Lin et al ‘Heterocyclic Derivatives of 2-(3,5-Dimethylphenyl)tryptamine as GnHR Receptor Antagonists.’ Bioorganic & Medicinal Chemistry Letters, 2001, vol. 11, pp. 1077-1080.
Simoene, J, P. ‘Synthesis of chiral β-methyl tryptamine-derived GnHR antagonists.’ Tetrahedron Letters, 2001, vol. 42, pp. 6459-6461.
Walsh et al ‘A convergent synthesis of (S)-β-methyl-2-aryltryptamine based gonadotropin releasing hormone antagonists.’ Tetrahedron, 2001, vol. 57, pp. 5233-5241.
Young et al ‘2-Arylindoles as Gonadotropin Releasing Hormone (GnHR) Antagonists: Optimization of the Tryptamine Side Chain.’ Bioorganic & Medicinal Chemistry Letters, 2002, vol. 12, pp. 827-832.
Ujjainwalla, F ‘Total synthesis of 6- and 7-azaindole derived GnHR antagonists.’ Tetrahedron Letters, 2001, vol. 42, pp. 6441-6445.
Simeone et al ‘Modification of the Pyridine Moiety of Non-peptidyl Indole GnHR Receptor Antagonists.’ Bioorganic & Medicinal Chemistry Letters, 2002, vol. 12, pp. 3329-3332.
Gibbs, J, B ‘Pharmaceutical Research in Molecular Oncology.’ Cell, 1994, vol. 792, pp. 193-198.
Bird Thomas Geoffrey
Maudet Mickael Louis Pierre
AstraZeneca AB
Stockton Laura L.
LandOfFree
Pyrazole derivatives as GnRH inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole derivatives as GnRH inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives as GnRH inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3886533